| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |